Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Drug Withdrawal Symptoms

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with Drug Withdrawal Symptoms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhalla, S; Gulati, A; Matwyshyn, G; Puppala, BL1

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Drug Withdrawal Symptoms

ArticleYear
Involvement of central endothelin receptors in neonatal morphine withdrawal.
    Experimental biology and medicine (Maywood, N.J.), 2006, Volume: 231, Issue:6

    Topics: Analgesics, Opioid; Animals; Animals, Newborn; Central Nervous System; Dansyl Compounds; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelins; Female; Guanosine 5'-O-(3-Thiotriphosphate); Morphine; Peptide Fragments; Pregnancy; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Substance Withdrawal Syndrome

2006